Literature DB >> 22124129

Vaccination with parenteral toxoid B protects hamsters against lethal challenge with toxin A-negative, toxin B-positive clostridium difficile but does not prevent colonization.

Farida Siddiqui1, Jennifer R O'Connor, Kristin Nagaro, Adam Cheknis, Susan P Sambol, Gayatri Vedantam, Dale N Gerding, Stuart Johnson.   

Abstract

Toxin A has historically been regarded as the primary virulence determinant in Clostridium difficile infection, but naturally occurring toxin A-negative, toxin B-positive (A-/B+) C. difficile strains are known to be virulent. To determine the role of toxin B in these strains, we immunized hamsters with a toxoid prepared from purified toxin B to determine whether they would be protected from lethal challenge with an A-/B+ strain of C. difficile.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22124129     DOI: 10.1093/infdis/jir688

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

Review 1.  The potential for emerging therapeutic options for Clostridium difficile infection.

Authors:  Harsh Mathur; Mary C Rea; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Gut Microbes       Date:  2014

Review 2.  Vaccines against Clostridium difficile.

Authors:  Rosanna Leuzzi; Roberto Adamo; Maria Scarselli
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

3.  A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection.

Authors:  Haiying Wang; Xingmin Sun; Yongrong Zhang; Shan Li; Kevin Chen; Lianfa Shi; Weijia Nie; Raj Kumar; Saul Tzipori; Jufang Wang; Tor Savidge; Hanping Feng
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

4.  Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against Clostridium difficile.

Authors:  Caixia Tan; Fei Zhu; Yuanyuan Xiao; Yuqi Wu; Xiujuan Meng; Sidi Liu; Ting Liu; Siyao Chen; Juan Zhou; Chunhui Li; Anhua Wu
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

5.  Protection from Clostridium difficile infection in CD4 T Cell- and polymeric immunoglobulin receptor-deficient mice.

Authors:  Pehga F Johnston; Dale N Gerding; Katherine L Knight
Journal:  Infect Immun       Date:  2013-11-11       Impact factor: 3.441

6.  Vaccination against Clostridium difficile using toxin fragments: Observations and analysis in animal models.

Authors:  Janice Spencer; Rosanna Leuzzi; Anthony Buckley; June Irvine; Denise Candlish; Maria Scarselli; Gillian R Douce
Journal:  Gut Microbes       Date:  2014-01-22

7.  A chimeric protein comprising the glucosyltransferase and cysteine proteinase domains of toxin B and the receptor binding domain of toxin A induces protective immunity against Clostridium difficile infection in mice and hamsters.

Authors:  Yuan-Kai Wang; Ya-Xian Yan; Hyeun Bum Kim; Xianghong Ju; Song Zhao; Keshan Zhang; Saul Tzipori; Xingmin Sun
Journal:  Hum Vaccin Immunother       Date:  2015-06-02       Impact factor: 3.452

8.  A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile.

Authors:  Bao-Zhong Zhang; Jianpiao Cai; Bin Yu; Yanhong Hua; Candy Choiyi Lau; Richard Yi-Tsun Tsun Kao; Kong-Hung Sze; Kwok-Yung Yuen; Jian-Dong Huang
Journal:  BMC Infect Dis       Date:  2016-10-22       Impact factor: 3.090

9.  Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains.

Authors:  Susan Secore; Su Wang; Julie Doughtry; Jinfu Xie; Matt Miezeiewski; Richard R Rustandi; Melanie Horton; Rachel Xoconostle; Bei Wang; Catherine Lancaster; Adam Kristopeit; Sheng-Ching Wang; Sianny Christanti; Salvatore Vitelli; Marie-Pierre Gentile; Aaron Goerke; Julie Skinner; Erica Strable; David S Thiriot; Jean-Luc Bodmer; Jon H Heinrichs
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

Review 10.  A Review of the Safety and Efficacy of Vaccines as Prophylaxis for Clostridium difficile Infections.

Authors:  Mackenzie Henderson; Amanda Bragg; Germin Fahim; Monica Shah; Evelyn R Hermes-DeSantis
Journal:  Vaccines (Basel)       Date:  2017-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.